![Jaap Koopman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jaap Koopman is the founder of Profibrix BV, serving as Chief Scientific Officer since 2004.
Dr. Koopman is the founder of Fibriant BV, serving as Chief Executive Officer since 2015.
Former job includes Scientific Director & Project Manager at Pharming Group NV from 1998 to 2003.
Education includes a doctorate from the University of Leiden, conferred in 1992.
Aktive Positionen von Jaap Koopman
| Unternehmen | Position | Beginn |
|---|---|---|
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Gründer | 01.01.2004 |
Fibriant BV
 Fibriant BV Pharmaceuticals: OtherHealth Technology Provides research and development of of human fibrinogen | Vorstandsvorsitzender | 01.01.2015 |
Ehemalige bekannte Positionen von Jaap Koopman
| Unternehmen | Position | Ende |
|---|---|---|
| PHARMING GROUP N.V. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 |
Ausbildung von Jaap Koopman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
28
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Pharming Group NV
 Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology Develops and markets products for the hemostasis and regenerative medicine markets | Health Technology |
Fibriant BV
Fibriant BV Pharmaceuticals: OtherHealth Technology Provides research and development of of human fibrinogen | Health Technology |
Wählen Sie MarketScreener 
